Radionuclide angiography and endomyocardial biopsy in the assessment of doxorubicin cardiotoxicity

Cancer

Volumn 53, Issue 8, 1984, Pages 1667-1674

  Druck, Maurice N ^a   Gulenchyn, Karen Y ^a   Evans, William K ^a   Gotlieb, Avrum ^a   Srigley, John R ^a   Bar‐Shlomo, Ben‐Zion ^a   Feiglin, David H ^a   McEwan, Patricia ^a   Silver, Malcolm D ^a   Millband, Linda ^a   Winter, Kathy ^a   Hilton, J David ^a   Jablonsky, George ^a   Morch, John E ^a   McLaughlin, Peter ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; FLUOROURACIL; PREDNISONE; PROCARBAZINE; RADIOISOTOPE; VINBLASTINE; VINCRISTINE;

CANCER COMBINATION CHEMOTHERAPY; CARDIOMYOPATHY; CARDIOTOXICITY; CLINICAL ARTICLE; DIAGNOSIS; DRUG TOXICITY; ELECTROCARDIOGRAPHY; EXERCISE; HEART; HEART MUSCLE BIOPSY; HUMAN; INTOXICATION; INTRAVENOUS DRUG ADMINISTRATION; SCINTIANGIOGRAPHY; THERAPY;

ADULT; AGED; BIOPSY; CORONARY VESSELS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; ELECTROCARDIOGRAPHY; EXERTION; FEMALE; HEART DISEASES; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; PHYSICAL EXAMINATION;

EID: 0021136240     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19840415)53:8<1667::AID-CNCR2820530808>3.0.CO;2-D     Document Type: Article

References (45)

1. Adriamycin: A new anticancer drug with significant clinical activity
2. Phase II evaluation of adriamycin in human neoplasia
3. A clinicopathologic analysis of adriamycin cardiotoxicity
4. Adriamycin (NSC‐123127) cardiomyopathy: An overview with determination of risk factors
5. Adriamycin cardiomyopathy: Risk factors
6. Adriamycin (NSC‐123127) cardiotoxicity: A clinicopathological correlation
7. Risk factors for doxorubicin‐induced congestive heart failure
8. Doxorubicin cardiomyopathy: Evaluation by phonocardiography, endomyocardial biopsy, and cardiac catheterization
9. Some recent advances in cardiac pathology
10. Cardiotoxicity of Adriamycin (NSC‐123127) in children
11. Adriamycin cardiotoxicity in children: Case reports, literature review, and risk factors
12. Adriamycin and radiation: Synergistic cardiotoxicity (letter)
13. Adriamycin cardiotoxicity: Endomyocardial biopsy evidence of enhancement by irradiation
14. Echocardiography in Adriamycin cardiotoxicity
15. Echocardiographic evaluation of Adriamycin cardiotoxicity in children
16. Doxorubicin cardiotoxicity: Serial endomyocardial biopsies and systolic time intervals
17. Anthracycline cardiomyopathy monitored by morphologic changes
18. Left ventricular endomyocardial biopsy: I. Description and evaluation of the technique
19. Cardiac evaluation from radioisotopic dynamics
20. Nontraumatic determination of left ventricular ejection fraction by radionuclide angiocardiography
21. Sequential radionuclide assessment of left and right ventricular performance after acute transmural infarction
22. Assessment of cardiac performance with quantitative radionuclide angiocardiography: Effects of oral propranolol on global and regional left ventricular function in coronary artery disease
23. Analysis of left ventricular function from multiple gated acquisition cardiac blood pool imaging: Comparison to contrast angiography
24. Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography
25. Specificity and sensitivity of radionuclide ejection fractions in doxorubicin cardiotoxicity (Abstr)
26. Cardiotoxicity of 5‐fluorouracil
27. Fluorouracil cardiotoxicity
28. Fluorouracil cardiotoxicity
29. 5‐Fluorouracil cardiotoxicity
30. 5‐Fluorouracil and angina
31. Cardiotoxicity of 5‐fluorouracil (NSC 19893)
32. Correlation of 5‐fluorouracil (NSC 19892): Distribution in rodents with toxicity and chemotherapy in man
33. In vivo labelling of red blood cells with 99mTc: A new approach to blood visualization
34. Techniques for right and left ventricular endomyocardial biopsy
35. Doxorubicin cardiotoxicity: Assessment by endomyocardial biopsy and radionuclide angiography (Abstr)
36. Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion
37. Invasive and noninvasive methods of assessing Adriamycin cardiotoxic effects in man: Superiority of histopathologic assessment using endomyocardial biopsy
38. Global and regional left ventricular response to bicycle exercise in coronary artery disease: Assessment by quantitative radionuclide angiography
39. Obstructive versus nonobstructive asymmetric septal hypertrophy: Differences in left ventricular function with exercise (Abstr)
40. Left ventricular function in aortic stenosis: Response to exercise and effects of operation (Abstr)
41. Exercise‐induced left ventricular dysfunction in symptomatic and asymptomatic patients with aortic regurgitation: Assessment by radionuclide cineangiography
42. Multiple gated blood pool imaging for left ventricular ejection fraction: Validation of the technique and assessment of variability
43. Overview of cardiac pathology in relation to anthracycline cardiotoxicity